Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
about
Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcomaRadiotherapy for localised Ewing’s sarcoma in childrenThe importance of PET/CT in the evaluation of patients with Ewing tumorsSequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesEwing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor in the Cerebellopontine Angle : Diagnosis and Treatment.RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.Chemotherapy in Ewing's sarcoma.Targeted Therapy of Ewing's Sarcoma.Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.Differential disruption of EWS-FLI1 binding by DNA-binding agents.Resection of pulmonary metastases in pediatric patients with Ewing sarcoma improves survival.Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy3D tissue-engineered model of Ewing's sarcomaVariable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma.Should Aggressive Surgical Local Control Be Attempted in All Patients with Metastatic or Pelvic Ewing's Sarcoma?Significance of local treatment in patients with metastatic soft tissue sarcoma.Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosinePrognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.Molecular profiling of childhood cancer: Biomarkers and novel therapiesMiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.Imaging pediatric bone sarcomas.Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites.Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.An Unusual Location of Extraosseous Ewing's Sarcoma.Thoracic Presentations of Small Round Blue Cell Tumors.New Technologies for Diagnosing Pediatric Tumors Expert Opinion on Medical Diagnostics.Molecular imaging for early prediction of response to Sorafenib treatment in sarcoma.Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report.Primary primitive neuroectodermal tumor of the urinary bladder: a case report and literature review.Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.Targeted therapy in bone and soft tissue sarcoma in children and adolescents.Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing's sarcoma.A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.Delayed Spinal Epidural Hematoma after En Block Spondylectomy for Vertebral Ewing's Sarcoma.Management and Outcome of Ewing Sarcoma of the Head and Neck.
P2860
Q24185945-AAC44273-1C77-4A25-9CE2-5AF022BFC6F6Q24194874-4741E5F7-39F9-4C47-949B-23DF64C32376Q26799775-D9BC3A44-B25E-4303-B6A0-233A4B2E44F4Q26801785-E6E21153-3C53-4305-9B43-7645355259B8Q30474363-FCCBDF8A-6E3A-41D6-8A94-49A7545BED4FQ33662727-C8E5F03F-6595-47A1-8817-AF87F647AA3BQ33861072-2E5F8732-917B-4828-ABB1-703DEEE79571Q33873775-165607FE-F375-4B7F-9986-CA90DF48E3B9Q34164686-AE7E150A-2235-46FB-9AEB-28C733B605D0Q34262377-157381E7-259D-48C0-B685-E02FC86F8CACQ34702270-9254E8AF-17EA-40C4-B2E4-F1165F4A4D77Q34874355-27AD1A7B-2701-439C-A611-B14CC6A0C0BEQ34989361-65538C44-C87A-42A5-A43A-305F9CAAD636Q35144928-AEE4501E-3C95-4DF7-9C9C-900551D35979Q35428655-5E6D3190-CC31-4D83-89CA-23BDF08A2526Q35545322-17B41D9A-2F22-41C3-8810-11107B775D48Q35832436-D95CBBE9-3533-411D-973E-7B81166CAA24Q35897904-E57863AF-8EB2-4AA2-A892-AFF7C597402DQ35929870-7130F5A3-DD83-406D-A353-5140D0498834Q35987417-1E4BD7EE-3E46-4977-95FD-11E01E1136B8Q35995816-B85F9766-8F77-40EA-9F9A-BB9A94FBABCDQ36250783-74BDB575-5595-4647-8DED-44D559E2361AQ36380991-939C3833-7E89-4515-89AB-29A691F93766Q36499007-7180C176-0A0C-4E47-8642-B99468B10F4AQ36849620-0522A949-8164-44AE-983E-F7495EF5BD62Q36930039-5477CE2F-8093-4383-893D-98030B196E87Q37049291-C1A61A13-AA95-4164-AFB0-3FDE9A25A785Q37050995-9D64ED8A-EA9B-45BE-9A38-DC5CAA11B040Q37238431-DADA7F92-BD1F-4FB1-A0A8-C204F647D421Q37402623-0F5BA1CA-BDB2-42C2-A417-19250865A55FQ37634905-8F11D2D9-D496-42D8-8BC0-789A34267CE7Q37790293-6998415A-C7EF-4043-BE9A-7C92564CD185Q37954566-21298EE1-57DD-4CD5-9EA3-AE6BB97EB662Q37981129-EA898D01-8C5A-41C6-8FB0-A1B615F5F690Q38006606-3E86B391-0431-48F3-AEBC-712D33B7661AQ38120777-8D376E91-E16B-4A94-A4A1-173C1A4399C5Q38184581-F8D0882C-5F6C-4A2F-A0FA-F3236F5F180DQ38334606-E38CA39A-E2E1-4C70-B078-601509306005Q38478801-8A6BBC5C-B35C-48CD-80C1-9279E5CA3855Q38678925-48E7859A-F6F4-4ED0-AC43-EFCD41EE8118
P2860
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@en
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@nl
type
label
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@en
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@nl
prefLabel
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@en
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@nl
P1476
Ewing sarcoma: historical pers ...... argeted therapy in the future.
@en
P2093
Joseph A Ludwig
P304
P356
10.1097/CCO.0B013E328303BA1D
P577
2008-07-01T00:00:00Z